352 related articles for article (PubMed ID: 27762727)
1. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727
[TBL] [Abstract][Full Text] [Related]
2. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
3. Transaxillary robotic modified radical neck dissection: a 5-year assessment of operative and oncologic outcomes.
Kim MJ; Lee J; Lee SG; Choi JB; Kim TH; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jo YS; Chung WY
Surg Endosc; 2017 Apr; 31(4):1599-1606. PubMed ID: 27572060
[TBL] [Abstract][Full Text] [Related]
4. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
Eweida AM; Sakr MF; Hamza Y; Khalil MR; Gabr E; Koraitim T; Al-Wagih HF; Abo-Elwafa W; Ezzat Abdel-Aziz T; Diab AA; El-Sabaa B; Nabawi AS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1951-1958. PubMed ID: 27999997
[TBL] [Abstract][Full Text] [Related]
5. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2012 Mar; 36(3):593-7. PubMed ID: 22207493
[TBL] [Abstract][Full Text] [Related]
6. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
Ryu YJ; Cho JS; Yoon JH; Park MH
World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of oncological outcomes and quality of life after robotic versus conventional open thyroidectomy with modified radical neck dissection in patients with papillary thyroid carcinoma and lateral neck node metastases.
Lee J; Kwon IS; Bae EH; Chung WY
J Clin Endocrinol Metab; 2013 Jul; 98(7):2701-8. PubMed ID: 23678034
[TBL] [Abstract][Full Text] [Related]
8. Routine Level 2b Dissection may be Recommended Only in N1b Papillary Thyroid Carcinoma with Three- or Four-Level Lateral Lymph Node Metastasis.
Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):694-700. PubMed ID: 27654111
[TBL] [Abstract][Full Text] [Related]
9. Patterns, predictive factors and prognostic impact of multilevel metastasis in N1b papillary thyroid carcinoma.
Kim SK; Park I; Hur N; Choe JH; Kim JH; Kim JS
Br J Surg; 2017 Jun; 104(7):857-867. PubMed ID: 28295219
[TBL] [Abstract][Full Text] [Related]
10. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
Wu Y; Li J; Wu X; Dai L
Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528
[TBL] [Abstract][Full Text] [Related]
11. Is level V dissection necessary for low-risk patients with papillary thyroid cancer metastasis in lateral neck levels II, III, and IV.
Yu WB; Tao SY; Zhang NS
Asian Pac J Cancer Prev; 2012; 13(9):4619-22. PubMed ID: 23167390
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic lymphadenectomy of neck level II in clinically node-positive papillary thyroid carcinoma.
Koo BS; Seo ST; Lee GH; Kim JM; Choi EC; Lim YC
Ann Surg Oncol; 2010 Jun; 17(6):1637-41. PubMed ID: 20146100
[TBL] [Abstract][Full Text] [Related]
13. Level II lateral neck dissection for papillary thyroid carcinoma: A retrospective cohort study.
Lv T; Ma WL; Tan Z; Jiang LH; Liang JY; Wu JJ; Hou CJ; Ge MH; Wang JF
Asian J Surg; 2023 Oct; 46(10):4290-4295. PubMed ID: 37085417
[TBL] [Abstract][Full Text] [Related]
14. Dissection of Levels II Through V Is Required for Optimal Outcomes in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma.
Javid M; Graham E; Malinowski J; Quinn CE; Carling T; Udelsman R; Callender GG
J Am Coll Surg; 2016 Jun; 222(6):1066-73. PubMed ID: 27049777
[TBL] [Abstract][Full Text] [Related]
15. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
[TBL] [Abstract][Full Text] [Related]
16. Central Lymph Node Dissection Improves Lymph Node Clearance in Papillary Thyroid Cancer Patients with Lateral Neck Metastases, Even after Prior Total Thyroidectomy.
Hall CM; Snyder SK; Lairmore TC
Am Surg; 2018 Apr; 84(4):531-536. PubMed ID: 29712601
[TBL] [Abstract][Full Text] [Related]
17. Factors Related to Lymph Node Recurrence in Patients with N1b Papillary Thyroid Carcinoma after Unilateral Therapeutic Modified Radical Neck Dissection: A Meta-analysis.
Su H; Li Y
Zentralbl Chir; 2018 Aug; 143(4):373-379. PubMed ID: 30134497
[TBL] [Abstract][Full Text] [Related]
18. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
19. "Scarless" (in the neck) endoscopic thyroidectomy (SET) with ipsilateral levels II, III, and IV dissection via breast approach for papillary thyroid carcinoma: a preliminary report.
Yan H; Wang Y; Wang P; Xie Q; Zhao Q
Surg Endosc; 2015 Aug; 29(8):2158-63. PubMed ID: 25427410
[TBL] [Abstract][Full Text] [Related]
20. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
